Barias, Emma .

HRN: 27-68-09  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/20/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/20/2025
08/26/2025
IV
2.25g
Q8
Cap Hr
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines